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It  was  previously shown  th  t  cultured  human  and  Chinese  hamster  cells are  re- 
spectively killed when treated with a  1% solution of the homologous rabbit antiserum 
in  the presence  of  complement,  but  not by  the heterologous antiserum.  Cell killing 
is accompanied  by  cytoplasmic leakage  from  the  cell,  so presumably  involves lysis 
at  antigenic  sites  on  the  cell surface  (1).  Hybrid  clones formed  from  the  fusion  of 
auxotrophic  Chinese hamster  cells and human fibroblasts retain or lose this capacity 
to be killed, in accordance with a  pattern  to be expected of a  simple genetic charac- 
teristic. This lethal human antigenic activity, which was named AL, was shown to be 
linked to the lactic dehydrogenase A  marker  (2). 
In the present paper,  the distribution  of AL on various human  cells has been 
studied  and  another lethal antigenic marker,  BL, has been shown  to be present 
on certain human  cell surfaces. 
Materials and Methods 
Tissue Culture Media and  Cells.--The  CHO-K1  Chinese  hamster  ovary  cell and auxo- 
trophic mutants isolated from it were employed in these experiments. The production, char- 
acterization,  and  mode of cultivation of  these mutants  have been  described  (3,  4).  These 
cells and  the human-Chinese hamster  cell hybrids obtained from them were grown in F12 
medium (5) or F12 from which specific omissions  were made as required by the needs of each 
experiment. All growth media were supplemented either with 5-10% of fetal calf serum or 
with an  equivalent amount  of its macromolecular components.  Hybridization  experiments 
utilized the appropriate, deficient media required to isolate the desired hybrids and were sup- 
plemented by the macromolecular fraction of fetal calf serum (6). Most hybrids were propa- 
gated in complete media after 1 mo. Some, however, required continuous cultivation in de- 
ficient media to maintain chromosomal constancy. Standard F12 (5) supplemented with 10% 
fetal calf serum (F12FC10) was used for the single-cell platings involved in the antigen assay 
experiments. 
The cultured human cells were the $3 clone of HeLa, normal human skin fibroblasts, and 
normal fibroblast-like cells derived from amniotic fluid,  the latter two cell types behaving 
similarly in all the experiments reported here. HeLa cells were grown in plastic culture dishes 
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or as suspension cultures in F 12 supplemented  with 10% of fetM calf serum. Human fibroblasts 
were cultivated in F12  supplemented with 10% fetal calf serum and 5% human cord serum. 
For  the single-cell  plating in the antigenic assay experiments the human cord serum was 
omitted, since it slightly neutralized the effects of antiserum and was found not to be neces- 
sary for the growth of colonies of the human fibroblasts in short-term experiments. 
Hybrid clones,  selected from virus-mediated fusions of Chinese hamster auxotrophic mu- 
tants and human cells from a variety of sources, have been described (2, 7). These previously 
isolated primary clones, plus newly formed similar primary clones, and a variety of subclones 
selected from both these primary sources were employed in  the present study. The term 
"hybrid clone" in this paper always refers to the result of hybridization of a human cell with 
an appropriate CHO-K1 auxotroph. 
Preparation of Antisera.--Most of  the tissue culture cells utilized as antigens were har- 
vested with 0.05% trypsin. Some HeLa cells and Chinese hamster cells were harvested with- 
out  trypsin from suspension cultures.  One  rabbit was immunized with human fibroblasts 
harvested from plastic plates by scraping. No differences attributable to method of harvest- 
ing were noted. Red blood cells  (RBCs) i were purified by careful removal of the buffy coat. 
In subsequent washings, red cells were taken from the bottom of the tube to minimize leuko- 
cyte contamination. White blood ceils used for immunization were obtained by removal of 
the buffy coat from human blond.  Residual RBCs were subjected to hypotonic lysis and re- 
peated washing to remove membranous debris. All cells were washed at least three times in 
physiological saline. 
Antigens were prepared by suspending tissue culture cells in a  concentration of 5  X  l07 
cells/ml of saline, or blond ceils prepared as described in a concentration of 2 X  10S/ml  of 
saline. The larger number of the latter cells was used to compensate approximately for their 
smaller surface area. An equal volume of Freund's adjuvant (Difco Laboratories, Inc., De- 
troit, Mich.) was emulsified with each cell suspension just before injection. Similar  antigens 
were used for both sheep and rabbit immunizations. The rabbits received injections of 1.0 
ml of antigen intramuscularly while the sheep received 5.0 ml. A second injection of the same 
antigen was given to  each immunized animal after 2 wk.  Serum titers were checked at 4 
wk. Those animals with low  titers received a  third injection of the same antigen. 
Horse antiserum to pooled, cultured human cells of "lymphocytic" origin (HAHL)  was 
supplied by Dr. Noboru Kashiwagi (Department of Surgery, Veteran's Administration Hos- 
pital, Denver, Colo.).  The immunization was effected by one subcutaneous injection of the 
cell suspension plus adjuvant. Weekly booster shots were given intravenously without addi- 
tional adjuvant (8). 
A standard pooled, rabbit antihuman cell serum (RAHC) with a high titer of AL antibody 
was prepared by combining pretested lots of rabbit antisera to cultured A  + human fibroblasts 
and HeLa cells. 
Adsorption  of  Specific  Cell-Lethal  Antibodies from  Antisera.--Tissue  culture  ceils  were 
grown in monolayers in F12 medium plus 10% of fetal calf serum. Confluent plates were har- 
vested with trypsin that was inactivated with 5%  fetal calf  serum after  the cells  were re- 
leased from the surface. The cells were then washed three times in saline before adsorption. 
In one experiment HLea cells were grown in  suspension so that no  trypsinization was re- 
quired. 
Human RBCs for adsorption were obtained from heparlnized blood. Human lymphocytes 
from heparinized blood were prepared with modifications of the differential sedimentation 
method of Thorsby and Bratlie (9). Preliminary RBC removal was aided by the addition of 
dextran. The leukocyte-rich plasma was centrifuged at 280 g.  The pellet containing leuko- 
1 Abbreviations used  in  this paper: HAHL, horse antihuman lymphocyte serum;  RAHC, 
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cytes and some RBCs was suspended in isotonic saline, pH 6.5, and layered over a  1.077 g/ml 
F icoll-Hypaque (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.; Winthrop Laboratories, 
New York) cushion in the bottom of a centrifuge tube. Centrifugation was carried out for 40 
min at 380 g. The purified lymphocyte layer was removed from the interface of the saline and 
the Ficoll-Hypaque high-density cushion. Harvested lymphocytes were then washed three 
times in saline. 
The antisera were heated to 56°C for 30 min before adsorption. Cells and heated antisera 
were placed together in plastic tubes (Falcon no. 2003; Falcon Plastics, Division of BioQuest, 
Oxnard, Calif.)  12 mm in diameter to a depth not to exceed 1 cm. Control tubes of the sera 
were included to which no cells were added. Tubes with adsorbing cells and antisera were 
incubated in a 37°C water bath shaker for 2 h with vigorous shaking (200 excursions of 1.5 
cm amplitude per minute). Cells adsorbing antibodies usually agglutinate while nonaggluti- 
nated cells remain in  suspension under these conditions. At  the end of the incubation an 
equal volume of saline G  (10) was added to each tube to maximize serum collection. All the 
cells were then sedimented by centrifugation and the diluted serum was removed and  steri- 
lized by Mi]lipore filtration (Millipore Corp., Bedford, Mass.). Experiment demonstrated that 
tissue culture cells in a concentration of 5 X  10 T cells per ml removed all detectable killing 
activity from homologous rabbit antisera under these conditions. This number of cells was 
used in all the standard adsorption tests, unless specified to the contrary. Other cell numbers 
were  employed in  special  experiments as  indicated. 
Complement.--Initial experiments were performed with fresh, unheated rabbit antiserum 
(2). In the results here reported fresh complement was added to the heated sera. Guinea pig 
complement as reported by Oda and Puck  (1) was satisfactory for HeLa cell assays but was 
toxic to the CHO-K1 parental cell and most hybrid cells. Normal rabbit serum, though occa- 
sionally toxic, was found to be a superior source of complement for these experiments (11). 
Normal rabbits were bled by heart puncture and the blood was permitted to clot at 
room temperature. The serum was collected, filtered for sterility, and frozen for storage in 
1- and 2-ml samples at  -70°C. Such handling precluded activity loss by thawing and re- 
freezing.  At the time of filtration the serum was tested for complement activity and non- 
specific cytotoxicity. Lots that showed toxicity or substandard activity were discarded. Frozen 
complement was  stored for a  maximum  of 4  wk. 
Assay of Antigens by Single-Cell Plating.--The basic techniques for screening of clones for 
the presence of AL antigen consisted in making the following additions to each of a series of 
35-ram plastic culture dishes: 1 ml of F12 medium supplemented with 10% fetal calf serum, 
0.05 ml of a  1:10 dilution of heated test serum, 0.02  ml of rabbit complement, and 200 test 
cells. The test cells were harvested with trypsin from vigorously growing culture plates. The 
plates were incubated for 7-8 days, fixed,  stained, and scored for the number of developed 
colonies.  From these counts the plating efficiencies were determined. Controls were set up 
in the same manner containing only complement on the one hand, and only heated normal 
rabbit serum on the other in place of the antiserum. Other controls included plates in which 
susceptible cells consisting of parental cells  or hybrids of known A  + character were tested 
against a  standardized antiserum-like RAHC. All platings were made in duplicate. 
Plating the cells  first and permitting attachment before the addition of antiserum and 
complement gave the same results as simultaneous addition of cells and reagents. Some hy- 
brids were somewhat sensitive to 2% normal rabbit serum used as complement. In such cases, 
1% complement gave clearer results. An antiserum was designated as killing if it decreased 
the plating efficiency by >__98% under the standard conditions. When finer distinctions were 
required, killing antisera were classified  as  +,  ++,  or  +++  depending on whether the 
amount of antiserum needed for __98% killing,  respectively, lay in the intervals between 2.0 
and 1%; 1 and 0.1%; or  <0.1%. Antisera designated as -- yielded no detectable cell killing 
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The assays of •L  antigen were made in a similar manner. Rabbit complement was used at a 
concentration of 2%. Tests were made with horse antiserum to cultured human lymphocytes, 
which was preadsorbed with an A + hybrid containing only one or two human chromosomes. 
This particular antiserum had an extraordinarily high potency, such that a solution contain- 
ing 0.01%  of the antiserum completely destroyed susceptible cells. 
The assay plates were routinely incubated for 7 days. Colonies were counted and the rela- 
tive plating efficiency was expressed as a percent of the colony number on control plates with- 
out the test antiserum. The absolute plating efficiency of control plates generally ranged from 
60 to 80%. 
For construction of survival curves, the cell killing titers of various native or adsorbed 
antisera were determined for each cell type in the same way. A series of serum concentrations 
was tested, and the logarithm of the relative plating efficiency was plotted vs. the serum con- 
centration. All single-cell platings were performed at least in duplicate, and each experiment 
was repeated with similar results. 
Mutagenesis of a Hybrid Clone.--Clone 78-5zl  (2), a  typical, stable A  + hybrid containing 
approximately two human  chromosomes, was chosen as a  standard  A  + clone.  Cells of this 
clone were treated with the mutagen, ethylmethansulfonate, 385/~g/ml for 24 h (12), and then 
cultivated for 1 wk in standard  growth medium. The resulting culture was then exposed  to 
1% solution of an antiserum specifically  lethal to A  + cells, and new A[ subclones that grew 
out were isolated. These were examined for LDH-A isozyme. One of these clones to be dis- 
cussed later was found to be LDH-A  +. Another had  the more typical LDH-A- phenotype. 
This latter clone,  66-G9,  had  a  modal chromosome number  one less than  its parental  cell, 
78-5zl. In all other characteristics tested it was sirnilar  to the standard  A  + clone.  Therefore 
it was chosen as a standard AL clone. 
Isozyme Analysis.--The methods previously described  (2, 7) were employed with the fol- 
lowing  additions:  Isocitrate  dehydrogenase,  6-phosphogluconate  dehydrogenase,  peptidase 
A,  adenosine  deaminase,  and  nucleoside  phosphorylase  isozymes  were  electrophoretically 
separated by adopting procedures described by Meera Khan  (13).  Staining methods for the 
following enzymes were adopted from those described by the investigators cited: isocitrate 
dehydrogenase and 6-phosphogluconate from Meera Khan  (13);  peptidases from Lewis and 
Harris (14); adenosine deaminase from Spencer,  Hopkinson, and Harris (15); and nucleoside 
phosphorylase from Edwards, Hopkinson, and Harris (16). 
EXPERIMENTAL  RESULTS 
Linkage and Segregation between the A L and LDH-A  Genetic Determinants.- 
In  the previous paper  the linkage between  AL and LDH-A  was  inferred  from 
examination  of  76  clones  of  which  14  were  primary  and  the  rest  secondary 
(2).  Further  hybrids  have now been  prepared  so  that  by  this  time  a  total  of 
161  primary  and  secondary  clones  have  been  exanlined.  The  data  shown  in 
Table  I  would  appear  to  establish  the  linkage  between  the  AL  and  LDH-A 
markers  beyond any question. 
No  spontaneously  occurring  clone  containing  only  one  of  the  two  markers 
AL and LDH-A  has ever been found. However, a segregation of the two markers 
was  obtained  by  treatment  with  the  mutagen,  ethylmethansulfonate.  As 
described in the  Materials  and  Methods  section,  a  hybrid  A +  clone,  78-5zl, 
containing  both  markers  was  treated  with  the mutagen  by the  standard  tech- 
nique,  and the surviving cells were plated  in medium  containing  antiserum  so 
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TABLE I 
Evi4ence for Linkage Obtained  from Distribution of A + and LDH-A Markers Among Primary 
and  Secondary Clones of Human-Chlnese  Hamster  Cell ltybrids 
AL  + 
LDH-A  + 
Primary clones  5  0  0  20 
Secondary clones 
From A  + clones  62  0  0  37 
From A~ clones  0  0  0  37 
Total  67  0  0  94 
of the human LDH-A marker. One clone was found that is A~ but LDH-A  +. 
This experiment is of particular interest  because it presumably demonstrates 
how mutagenesis of genes on a human chromosome that is carried in the Chi- 
nese hamster hybrid can be carried out. 
Demonstration  of  Differences  in  Available  AL  Antigen  on  Cells  in  Different 
Differentiation  States.-- 
Demonstration  of differences  in  cellular  ability  to  elicit  killing  anlisera:  Dif- 
ferent kinds of human cells  were  injected by the standard methods described 
into experimental  animals  and  the  resulting  antisera  collected.  Table II pre- 
sents  a  summary of the  effectiveness of  such  antisera  as killing agents  when 
tested  against  different  cells.  The  rabbit  demonstrates  clear  differences  in 
antigenic  response  to  different  human  cells.  Injection of HeLa  cells,  human 
cultured fibroblasts, or human RBC results in antisera that are indistinguish- 
able by the procedures used in the experiments of Table I1. The human WBC, 
however, produce an antiserum that can kill  HeLa cells, but not cultured hu- 
man  fibroblasts  or  A  +  i_  hybrids  of  human  and  Chinese  hamster  cells.  This 
finding  suggests  that  the  WBC  possess  little  or  no  AL activity,  but  that  it 
and the HeLa share one or more other killing antigens not present on the cul- 
tured  human  fibroblast  or  the  A  +  hybrid. 
Results obtained with sheep antiserum were similar  to those obtained from 
the  rabbit  except that in  the  sheep  the  human  RBC  appears less  potent  an 
antigen for the AL marker than does the S3-HeLa or the fibroblast. The most 
potent antiserum of all  was obtained in a  horse in response to administration 
of  multiplying  human  cells  of  lymphocytic origin.  Its  antigenic  behavior, 
however,  resembles  that  of  actively multiplying fibroblasts,  rather  than  the 
nonreproducing human WBC. 
Demonstration  of differences in  cellular ability  to  adsorb  killing  activities from 
differenl  anlisera:  Better  definition  of  the  presence  of  available  antigen  is 
afforded by experiments in which standard antisera are adsorbed in a uniform 
fashion  by  different  cell  populations.  The  killing  activity  against  different 234  SURFACE  ANTIGENS  AS  GENETIC  MARKERS.  1I 
TABLE  II 
Qualitative  Demonstration  of the Existence  of Differences in Ability of Different  Cells to Produce 
Specific  Cell-Lethal Antibodies'* 
Animal  Cell used as antigen  immunized 
Killing  of test cells treated with each antiserum in 
presence of standard complement 
Standard 
Human  CHO-  Standard Ai~  A~- 
S3-HeLa  fibroblasts  K1  hybrid  hybrid 
Rabbit  S3-HeLa  ++  ++  --  ++  - 
Human cultured fibroblast  + +  + +  --  + +  -- 
Human RBC  ++  ++  -  ++  - 
Human WBC  ++  .... 
Sheep  S3-HeLa  +  +  + +  --  +  + 
Human fibroblast  + +  + +  -  + + 
Human RBC  +  +  --  + 
Horse  Long-term cultured cell  +++  +++  --  +++ 
of human lymphocytic 
origin 
* In the rabbit experiments two to six animals were injected with each antigen. The anti- 
sera,  produced  from  different  rabbits  similarly tested,  behaved  similarly.  One animal  for 
each antigen was used in the case of the sheep and horse, The table records the killing activity 
of each antiserum for each cell in the standard  plating  efficiency  experiment.  --  =  no de- 
tectable cell killing titer; +  =  0.02-0.01  ml antiserum/ml of solution required to kill 98% 
of the cells; ++  =  0.01 -- 0.001  ml antiserum  required;  +++  =  0.001  ml or less  anti- 
serum required. 
standard  test  cells of the  adsorbed  antisera  can  then  be determined  by direct 
single-cell titration. 
Fig.  1  presents  a  set  of  survival  curves  so  obtained.  These  data  illustrate 
that  three  cell  types--HeLa,  actively growing  human  fibroblast,  and  the  A + 
hybrid--are  all  highly  potent  in  adsorbing  killing  activity  for  the  standard 
A +  hybrid,  from  the  standard,  pooled,  RAHC  antiserum  prepared  against 
HeLa and human  fibroblast cells. On the other hand,  the human  nomnultiply- 
ing  lymphocyte,  the  human nonmultiplying  RBC,  the CHO-K1,  and  the  A~ 
hybrid  are  all ineffective in  adsorption  tests  carried  out  under  these  specified 
conditions.  These data  are consistent with those of Table I1 except in the case 
of the RBC, which showed A +  activity in the qualitative experiments of Table 
II,  but  not  in  the  quantitative  experiments  of  Fig.  1. 
In order to inquire more deeply into this apparent  discrepancy,  experiments 
were  carried  out  in  which  the  number  of  adsorbing  cells  was  varied,  but  in 
which  all  other  conditions  of  the  adsorption  test  remained  unchanged. 
In  Fig.  2  is  shown  a  typical  set  of  survival  curves  obtained  when  AL  +  cells 
are  exposed  to  standard  RAHC  antiserum  adsorbed  with varying numbers  of 
HeLa cells. From such curves, one can determine the percentage concentration PAUL  WUTHIER~  CAROL JONES~ AND  THEODORE  T.  PUCK  235 
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FI¢.  1. Demonstration that the standard pooled antiserum against human  cells  (RAHC) 
kills the standard A + hybrid cell in its unadsorbed state (•)  and is unchanged after adsorp- 
tion by the standard  technique with 5 X  107 of each of the following cells: human  RBCs 
(C)); human lymphocytes ([]) ; CHO-K1 (m) ; and the standard  At hybrid cell (~).  Note 
that adsorption with any of the four cells leaves the serum indistinguishable by this test from 
its native state. In contrast to this behavior, the standard  antiserum loses all of its killing 
potency for the standard A  + hybrid cell after adsorption with: the standard A  + hybrid itself 
(V); the S3-HeLa cell (~)); and the cultured human fibroblast (v  l). 236  SURFACE  ANTIGENS  AS  GENETIC  MARKERS.  1[ 
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FIG.  2.  The effect of changing  the concentration  of  adsorbing  cells on  the killing titer. 
HeLa cells  were used  in  the concentrations indicated for  adsorption  of RAHC  antiserum, 
which was then titrated for its killing action on the standard  A  + hybrid: unadsorbed  serum 
(O); 3  X  l0  s eells/ml (O);  1 X  10 6 cells/ml (@); 3  X  10 6 cells/ml (A);  1 X  10 7  cells/ 
ml (U). 
of  unadsorbed  serum  to  which  a  partially  adsorbed  serum  is  equivalent  in 
killing potency. 
Experiments  similar  to  those in  Fig.  2  were carried  out,  using human  RBC 
and  WBC  as  the  adsorbing  cells.  These  experiments  revealed  that  human 
lymphocytes  that  display  no  AL  activity  in  the  procedures  of  Table  II  or 
Fig.  1  can  indeed  remove anti-AL  activity from  the  standard  antisera  if their PAUL  WUTHIER~ CAROL JONES~ AND  THEODORE  T.  PUCK  237 
concentrations  are  raised  sufficiently3  If  one  employs  300  times  as  many 
human  lymphocytes as HeLa cells,  the  apparent  adsorptive capacity for AL 
antibody is as great for the former as the latter. This effect cannot be due to 
the  smaller surface of the lymphocyte compared to  the HeLa cell  since  the 
surface area of the latter is only about six times larger than that of the former. 
The behavior of the human lymphocyte then is consistent with the hypothesis 
that it contains  about l~00th  of the  available AL antigen as  the HeLa cell. 
We therefore designate this cell as A(~  >. 
The behavior of the human RBC is more complex. The human RBC  when 
injected into a rabbit or sheep produces an antiserum that exhibits some kill- 
ing activity against A + cells and none against A~ cells (Table II). The former 
killing  activity  can  be  adsorbed  out  almost  completely by 3 X  107/ml  A  + 
hybrid cells or by 1 X  109/ml RBC, indicating that the latter cell is only about 
3 %  as effective as the former in this specific adsorption. However, when all 
other conditions of the adsorption procedure are kept constant and only the 
cell  density is  varied,  even  concentration as  high  as  3 X  109/ml  of human 
RBC do not adsorb out the AL killing activity from antisera produced against 
HeLa or other A + cells. This anomalous behavior of the human RBC remains to 
be explored further. One hypothesis among several is that  the RBC contains 
antigenic sites that are only partially but not sufficiently similar to AL sites to 
duplicate all the activity of the latter. We therefore designate the human RBC 
as (A~) +. A summary of the relative adsorbing potency of the various human 
cells and  cell hybrids is  shown in  Table III. 
Demonstration of BL Antigenic Sites by Adsorption  Tests.--The highly potent 
horse  antiserum  against  human  tissue  culture  cells  of  lymphoid  origin  was 
selected for these experiments. This serum was adsorbed in separate experiments 
with  various A +  cells until  no  demonstrable  toxicity remained  when  tested 
with cells of the same clone as used for the adsorption. Each of the various 
adsorbed sera was then tested to see if any killing activity remained against 
cells other than that used in its own adsorption. 
In  Table  IV  are  demonstrated  the  results  obtained  when  the  standard 
(HAHL) antiserum was respectively adsorbed by S3-HeLa and by the stand- 
ard A + hybrid. The resulting sera were then tested against these same clones 
and against another A + cell hybrid. The data indicate that  the S3-HeLa cell 
has removed all killing  antibodies  capable of affecting any of the  three test 
cells employed. However, whereas the one A  + hybrid,  78-5zl, can remove all 
of the antibodies capable of killing itself, it leaves behind activity capable of 
killing  the  other  two  test  cells.  Therefore,  S3-HeLa and the  78-1f2  hybrid 
contain killing  antigens  different from their common AL antigen. 
2 In the case of the human white cells, the total WBC complement was used in prepara- 
tion of the antigen, but only lymphocytes in the adsorption experiments. Tests demonstrated 
that all of the killing action of the WBC antiserum for the test cells used here could be re- 
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TABLE III 
Rdatffe Adsorbing Ability of Various Human  Cells  and  Cell Hybrids 
Cell type  No. of cells needed to adsorb 80% of the anti-AL  activity  from RAHC 
HeLa 
Human fibroblast 
78-5zl (A~ hybrid) 
Human lymphocyte 
Human RBC 
66-G9 (A  L hybrid) 
1 X  10 6 
3 X  10 6 
1  X  10  7 
3 X 10 s 
No adsorption at any cell concentration tested 
No adsorption at any cell concentration tested 
TABLE IV 
Demonstration That Killing Antibodies Affecting Some but Not Other Cells Remain  When A +  L 
Antiserum  (HAHL)  Is Selectively  and Completely  Adsorbed with Specific Cells* 
Adsorbing  A  + cells 
Killing  effectiveness  of each specifically  adsorbed 
antiserum on the following test cells 
78-5zl hybrid  78-1f2 hybrid 
S3-HeLa  (A  +)  (A~) 
S3-HeLa  --  --  -- 
78-5zl hybrid  +  --  + 
*  -  means that the adsorbed antiserum in 2% concentration has no effect on the test 
cell, while +  means that it kills at least 98% of the test cells under the standard conditions. 
Since adsorption of  the  standard serum with  S3-HeLa  also removes all of 
itskilling activity for the 78-1f2 hybrid, these two cells must possess a common 
killing antigen. We name this antigen BL. Experiments revealed that the S3- 
HeLa  and the 78-1f2  hybrid A +  clones behave  similarly with  respect  to  BL 
activity, in their susceptibility to killing by specific antisera with and without 
+  + 
prior adsorption. Therefore these two cells can be designated as ALBL, while 
ALBL. By standard adsorption tests,  the human  the 78-5zl hybrid would be  +  - 
lymphocyte was also shown to be able to remove antibodies to BL,  as well as 
to produce  these,  as indicated in Table II. We designate the  lymphocyte as 
±  + 
A~.BL. 
The  cultured human fibroblast has  been  demonstrated both  by  antibody 
elicitation  and  by  specific  adsorption  to  contain BE,  but  preliminary tests 
indicate it to have less of this activity than the HeLa cell or the human lympho- 
cyte. However, all experiments searching for BL activity on the human RBC 
have been negative. Quantitative evaluation of these cell activities is in prog- 
ress. 
It is possible to  select B[  subclones from originally B +  clones by growing 
up populations of  the  latter in killing concentrations of  BL  antiserum. Such 
subclones have been picked and were found to be stable on continued cultiva- 
tion. Typical plates are shown in Fig. 3. Thus BL like AL appears capable of 
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FIG. 3. The specific killing of human-Chinese hamster hybrid cells with AL or BI~ antisera. 
Control plates with normal serum typically had 100-150 colonies from 200 cells plated.  With 
the appropriate  antiserum  the killing of (+)  hybrids  is virtually  complete but there  is  no 
killing of the (-) hybrids. The A~B[ clone was obtained from the AL  B+ clone by selection 
of an occasional surviving colony in the presence of BL antiserum. 
Table  V  illustrates  some of the different kinds of hybrid clones that are ob- 
tained  directly  or  through  selection  by  the  use  of  specific  antisera.  All  pos- 
sible combinations of the two antigenic markers have been prepared in different 
hybrids.  It may be  noted  that  whereas  AZ and  B~ clones are  often  obtained 
by the  use  of  the  appropriate  selective  antiserum  from  the  corresponding -}- 
+ 
clones, we have never yet obtained either an A + or a BL subclone from a  clone 
that  was  originally  lacking  the  respective  antigen,  a  fact  to  be  expected  if 
simple  genetic  relationships  are  obeyed. The  data  of Table  V  appear  to sup- 
port the conclusion that A~ and BL are unlinked since these markers are readily 
lost independently of each other. 
It  should  be  possible  to prepare  specific  antisera  against  AL and  BL sepa- 
rately not only by specific adsorption  of multivalent  antisera  with  the appro- 240  SURFACE  ANTIGENS  AS  GENETIC  I~ARKERS.  II 
TABLE  V 
Demonstration  of the  Killing  Antigen  Designation  of  Various  Hybrid  Clones and  Subclones 
Based  on  Ability  of Cells to  Be Killed  by  Specific  Antisera* 
Cell clones tested 
Human-Chinese hamster hybrid subclones  AL  BL 
Original clone  Derived by selection with specific antiserum 
78-5zl 
78-1f2 
78-1i 
66-G9 
78-1f2-R1 
78-1d-R4 
78-1d-R5 
78-1f2-RIA 
78-1f2-R1B 
78-1f2-RIC 
78-1f2-R1D 
78-1f2-R1E 
78-1f2-RIF 
78-1f2-RIG 
m 
+  + 
-  + 
-  + 
-  + 
-  + 
-  + 
-  + 
* The  data indicates independent segregation of  AL  and  B  L  markers. 
ALBL and ALBL  priate cells, but also by direct immunization of animals with  +  -  -  + 
clones,  respectively.  Such  an  immunization  has  been  carried  out  with  an 
+  -- 
ALBL clone in a  rabbit and resulted in an antiserum with a high lethal titer 
for human A  + cells.  This antiserum is,  of course, also lethal for the parental 
CHO-K1  and for all  the hybrids, because the  cell  used  as antigen contained 
all or most of the CHO-K1 genome. However, by exhaustive adsorption with 
an A~B~ hybrid clone, virtually all of the lethality for CHO-K1 was removed. 
As  was expected, the killing titer of the antiserum for the A  +  S3-HeLa cells 
was  unchanged.  It  also now kills  only A  + hybrids.  The resulting  antiserum 
presumably then contains antibodies only to those substances that are due to 
genes on the human chromosomal complement of the hybrid. This procedure 
offers promise of providing reasonably pure antibody reagents to gene prod- 
ucts  of  particular  human  chromosomes.  The  preparation  of  similar  specific 
antisera for the case of the BL marker is in progress. 
Further linkage studies on BL comparable to those already reported for AL 
have been undertaken. BL is unlinked to glucose 6-phosphate dehydrogenase 
and therefore is presumably autosomal. BL also appears to be unlinked to the 
following:  6-phosphogluconate  dehydrogenase,  phosphoglucomutase,  NAD- 
dependent  malate  dehydrogenase,  glutamic  oxaloacetic transaminase,  lactic 
dehydrogenase A,  lactic dehydrogenase B, isocitrate dehydrogenase, NADP- 
dependent  malate  dehydrogenase,  glucose  phosphate  isomerase,  adenosine 
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reductase leading  to  proline  synthesis,  and  serine  hydroxymethylase.  Cyto- 
genetic and further isozymic examination of the B + and B7 hybrids is under 
investigation  and  will  be described  in  forthcoming reports. 
By extension of these experiments it has been shown that sera from which 
all  AL and  BE  antibodies  have been  removed  still  possess the  ability  to kill 
S3-HeLa cells  and  cultured  human  fibroblasts.  Therefore  these  cells  appear 
to  possess  other  lethal  antigens  in  addition  to  AL  and  BL.  Preliminary  ex- 
periments show that some of these  additional  antigens  are and  some are not 
identical to each other. In Table VI is presented a summary of the lethal anti- 
gens so far identified on the various human cells used in this study. 
The concentration of complement used in these experiments is critical, since 
if  the  amount  is  altered,  the  apparent  amounts  of  the  antigens  carried  by 
TABLE  VI 
Current  Status  of Lethal  Antigens  on  the  Human  Cells  Here  Studied 
Evidence available for 
Cell type  AL  BL  existence of additional 
lethal antigens 
S3-HeLa  AL  +  BE  + 
Cultured human fibroblasts  AL  +  B  E  + 
Human RBC  (A~)  +  BL  -- 
Human lymphocyte  A[  ~)  B~-  + 
these  cells  are  altered.  Therefore,  all  experiments must  be  carried  out  on  a 
carefully  standardized  source  of  complement  whose  concentration  is  kept 
constant  throughout  the  series.  The role of complement in  altering  these re- 
sponses is under study. 
DISCUSSION 
Other investigators have demonstrated different categories of specific anti- 
gens on cultured  cells (17,  18),  on various differentiated cells (19  21),  and on 
interspecies hybrid cells (22,  23). Differences have been demonstrated both in 
production of specific antibodies and  their adsorption  to cells of different or- 
gans  in  both  allo-  and  heteroimmunologic  systems. 
The study described in the papers of this series differs from previous studies 
in that the following combination of methodologies has been used: (a) Hybrids 
between human and Chinese hamster cells have been employed which permit 
incorporation of one or a  small number of human chromosomes into a  stable 
clone whose genome is otherwise that of the Chinese hamster cell. This effects an 
enormous  simplification  in  the  range  of  human  antigens  produced  by  each 
clone. The Chinese hamster antigens can be disregarded in  these experiments 
by virtue of the demonstrated lack of cross-reactivity of the antigens from cells 
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(b)  Single-cell plating  has been used  as  the  technique for demonstrating  the 
presence of lethal antigens. It has provided clear distinction between antibody- 
sensitive  and  resistant  cell  populations  and  permitted  selective  isolation  oi 
resistant  clones  from  an  initially  sensitive  parental  population.  (c)  Genetic 
tests have been applied with the result that the human antigens studied appear 
to furnish excellent genetic markers. 
Genetic markers like AL and BL appear  to be particularly useful in  these 
hybrid cells since they can readily be made the basis for selection  procedures. 
These are human genes and should be capable of being studied for mutagenic- 
ity in these cells by methods described earlier. By the use of agents like caf- 
feine, which we have shown to introduce chromosome breaks with few or no 
gene mutations, it might be possible to produce terminal deletions in the hu- 
man chromosome carrying a  given gene so as to be able to map the distance 
between such a  gene and other human genes contained on the same chromo- 
some. The presence or absence of specific lethal antigens on mammalian cells 
can be shown by the (a)  ability of specific cells to elicit antibodies capable of 
killing other cells with known antigenic constitutions; (b) ability of the cell to 
adsorb  out  specific killing  antibodies  from particular  standardized  antisera; 
and  (c)  ability of a  cell to be killed specifically and quantitatively by stand- 
ardized antisera. The second method is more quantitative than  the first and 
is more widely applicable than the third since it is applicable to nonmultiply- 
ing cells like RBC and WBC. The results so far obtained by all three methods 
are reasonably consistent within the limitations of uncertainty of each proce- 
dure. 
The  experiments  reported  here  indicate  that  the  use  of  lethal  antigens, 
which  behave  as  good genetic markers,  can be  extended. Moreover, specific 
differentiated human  cells like the RBC  and  the lymphocyte have  antigenic 
constitutions different from those on particular human clones grown in tissue 
culture.  These  methods  may  permit  studies  on  cells  whose  differentiation 
states involve different surface antigens. 
The use of single-cell  plating provides a precise and quantitative measure- 
ment  of the  potency of lethal  antigens  on various cell  types. It  also  makes 
possible ready isolation of clones resistant to specific antisera so that genetic 
variants can be readily obtained and studied. By hybridization with a variety 
of  Chinese  hamster  auxotrophs  in  appropriate  selective  media,  the  human 
chromosome on which  the gene responsible for this antigenic activity should 
be  identifiable,  and  the linkage between  this  and  other human  genes deter- 
mined. By methods described earlier (24), it may be possible to identify the 
control genes that affect the operation of specific antigens. This approach might 
be useful  in  characterization of specific cell  antigens  of various  normal  and 
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SUM2~ARY 
A  second  surface  antigen,  BL,  lethal  in  the  presence  of  specific  antibody 
and  complement has  been  identified  on  some human  cells  and  shown  to  be- 
have  as  a  good genetic marker.  It is  autosomal,  unlinked  to  the  human  AL 
antigen  previously described,  and unlinked  to 15  other human genes.  The AL 
antigen,  which  is linked  to  the lactic dehydrogenase A  gene,  is found on  the 
HeLa,  the  cultured  human  fibroblast,  and  in  small  amounts  on  the  human 
lymphocyte. BL occurs on HeLa cells,  on cultured human fibroblasts,  and on 
human lymphocytes, but not on human RBCs. Hybrid cells formed by fusion 
of human  and  Chinese  hamster  cells  have  been  prepared  containing  each  of 
the four possible combinations of these two markers. Highly selective antisera 
sensitive  to  each  marker  separately  can  be  obtained.  The  use  of  single-cell 
plating  to demonstrate  the  presence  of the  antigens  and  of hybrid  cells  con- 
taining  desired  combinations  of the  markers  facilitates  study in  this  system. 
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